search
Back to results

Diabetes Prevention Program to Treat Overweight and Obesity (DPP-TOO)

Primary Purpose

Weight Loss, PreDiabetes

Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Modified Diabetes Prevention Program Curriculum
Sponsored by
Auburn University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Weight Loss focused on measuring community pharmacy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: ≥18 years old BMI ≥ 25kg/m2 (23 if Asian) Exclusion Criteria: Pregnancy

Sites / Locations

  • Auburn University

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Modified DPP

Arm Description

Participants in this arm will participate in the modified Diabetes Prevention Program curriculum.

Outcomes

Primary Outcome Measures

Weight loss
Change from baseline body weight
Change in A1c
Change from baseline A1c

Secondary Outcome Measures

Proportion of patients meeting DPP program criteria
Percentage of individuals meeting DPP criteria at baseline
Blood pressure change
Change from baseline blood pressure
Physical activity change
Change from baseline self-reported physical activity in minutes per week

Full Information

First Posted
August 22, 2022
Last Updated
April 24, 2023
Sponsor
Auburn University
search

1. Study Identification

Unique Protocol Identification Number
NCT05640869
Brief Title
Diabetes Prevention Program to Treat Overweight and Obesity
Acronym
DPP-TOO
Official Title
The Diabetes Prevention Program to Treat Overweight and Obesity
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
February 7, 2023 (Actual)
Primary Completion Date
August 1, 2023 (Anticipated)
Study Completion Date
December 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Auburn University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to demonstrate the efficacy of the diabetes prevention program for the treatment of overweight and obesity within the community pharmacy setting. The long-term goal is to demonstrate the potential to improve diabetes prevention efforts through expanded access to weight loss services provided in community pharmacies.
Detailed Description
An estimated 38% percent of U.S. adults currently has prediabetes. In individuals aged 65 years and older, the prevalence of prediabetes is 48.8%. Prediabetes is commonly a precursor to the development of type 2 diabetes (t2d). Approximately 5-10% of individuals with prediabetes progress to t2d annually, with 70% developing t2d within their lifetime. Obesity is a significant risk factor for both prediabetes and diabetes, and its prevalence is steadily increasing. In 2020, a combined 66.7% of U.S. adults were classified as overweight or obese. In individuals with prediabetes, interventions leading to a 5-10% decrease in baseline body weight decrease the risk for progression to t2d by 58% at three years and 71% for those aged 60 years and older. At ten and fifteen years, the risk was decreased by 34% and 27%, respectively, and diabetes progression was significantly delayed. Based on these findings, a structured lifestyle intervention program was developed and has been available for public use by the Centers for Disease Control and Prevention (CDC) since 2010. Despite significant resources for the implementation of the Diabetes Prevention Program (DPP), program dissemination and utilization remains low. There are currently 1,882 registered DPP providers nationwide. Due to the modest results attributed to significant efforts to increase the access to and participation in DPP programs across the country, consideration should be given to modifying the current approach to diabetes prevention efforts. In 2020, approximately 42.4% of American adults had obesity according to the 2021 State of Obesity: Better Policies for a Healthier America report. The prevalence of obesity has been steadily increasing for the last two decades. This upward trend is expected to continue this if effective and sustainable solutions are not employed. According to the CDC, in 2013-2016, 49.1% of adults reported having tried to lose weight within the last year. Searching "weight loss" in any internet browser will return over a billion results ranging from diet plans and weight loss programs to testimonials of individual weight loss journeys. Due to the prevalence of overweight and obesity, the demand for weight loss interventions, and the efficacy of weight reduction for decreasing the risk for t2d development, expanding access to evidence-based weight loss interventions has the potential to significantly advance diabetes prevention efforts nationwide by shifting the focus from preventing prediabetes to treating overweight and obesity. One major gap in the current treatment landscape is how to implement an effective program for adult weight loss with widespread impact. Given the prevalence and visibility of community pharmacies, this setting is ideal for the dissemination of weight management services. In order to assess the potential impact, this pilot study aims to implement a modified-DPP program and to assess the diabetes risk and health outcomes of individuals choosing to participate in the program..

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Weight Loss, PreDiabetes
Keywords
community pharmacy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Modified DPP
Arm Type
Experimental
Arm Description
Participants in this arm will participate in the modified Diabetes Prevention Program curriculum.
Intervention Type
Behavioral
Intervention Name(s)
Modified Diabetes Prevention Program Curriculum
Intervention Description
The modified DPP curriculum will be an exact copy of the current DPP curriculum except that references to the prevention of diabetes will be modified to prevention of health outcomes associated with overweight/obesity and/or management of overweight/obesity.
Primary Outcome Measure Information:
Title
Weight loss
Description
Change from baseline body weight
Time Frame
6 months
Title
Change in A1c
Description
Change from baseline A1c
Time Frame
3- and 6- months
Secondary Outcome Measure Information:
Title
Proportion of patients meeting DPP program criteria
Description
Percentage of individuals meeting DPP criteria at baseline
Time Frame
From enrollment, assessed once enrollment is complete, within 3 months of study start.
Title
Blood pressure change
Description
Change from baseline blood pressure
Time Frame
6 months
Title
Physical activity change
Description
Change from baseline self-reported physical activity in minutes per week
Time Frame
6 months
Other Pre-specified Outcome Measures:
Title
Participation and attrition
Description
Rate of participation and attrition
Time Frame
6 months
Title
Reasons for participation/non-participation
Description
Qualitative analysis through semi-structured interview
Time Frame
1 year
Title
Change in level of confidence in ability to motivate oneself to maintain dietary and physical activity behaviors for at least 6 months
Description
Change from baseline in level of confidence in motivating oneself to engage the included dietary and physical behaviors for at lease six months as assessed by "Self-efficacy for diet and exercise behaviors" tool. Domains include sticking to an exercise regimen, making time for exercise, sticking to a diet, reducing calories, reducing salt, and reducing fat. Scale 1 to 5; higher = more confident
Time Frame
6 months
Title
Change in Stage of Change for Weight Loss
Description
Change from baseline in stage of change (scale 1-5; 1= precontemplation, 2= contemplation, 3= preparation, 4= action, 5= maintenance)
Time Frame
6 months
Title
Change in Processes of Change for Weight Loss including the following processes: emotional re-evaluation, weight consequences evaluation, supporting relationships, and weight management actions
Description
Change from baseline in process of change (scale 0 to 100; higher = more active use of the process of change)
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: ≥18 years old BMI ≥ 25kg/m2 (23 if Asian) Exclusion Criteria: Pregnancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Courtney E Gamston, PharmD
Organizational Affiliation
Auburn University Harrison School of Pharmacy
Official's Role
Principal Investigator
Facility Information:
Facility Name
Auburn University
City
Auburn
State/Province
Alabama
ZIP/Postal Code
36849
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
22683128
Citation
Tabak AG, Herder C, Rathmann W, Brunner EJ, Kivimaki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012 Jun 16;379(9833):2279-90. doi: 10.1016/S0140-6736(12)60283-9. Epub 2012 Jun 9.
Results Reference
background
PubMed Identifier
30661888
Citation
Venkataramani M, Pollack CE, Yeh HC, Maruthur NM. Prevalence and Correlates of Diabetes Prevention Program Referral and Participation. Am J Prev Med. 2019 Mar;56(3):452-457. doi: 10.1016/j.amepre.2018.10.005. Epub 2019 Jan 17.
Results Reference
background
PubMed Identifier
35613987
Citation
Joiner KL, McEwen LN, Hurst TE, Adams MP, Herman WH. Domains from the health belief model predict enrollment in the National Diabetes Prevention Program among insured adults with prediabetes. J Diabetes Complications. 2022 Jul;36(7):108220. doi: 10.1016/j.jdiacomp.2022.108220. Epub 2022 May 17.
Results Reference
background
PubMed Identifier
30044214
Citation
Martin CB, Herrick KA, Sarafrazi N, Ogden CL. Attempts to Lose Weight Among Adults in the United States, 2013-2016. NCHS Data Brief. 2018 Jul;(313):1-8.
Results Reference
background
PubMed Identifier
3432232
Citation
Sallis JF, Grossman RM, Pinski RB, Patterson TL, Nader PR. The development of scales to measure social support for diet and exercise behaviors. Prev Med. 1987 Nov;16(6):825-36. doi: 10.1016/0091-7435(87)90022-3.
Results Reference
background
PubMed Identifier
19360014
Citation
Andres A, Saldana C, Gomez-Benito J. Establishing the stages and processes of change for weight loss by consensus of experts. Obesity (Silver Spring). 2009 Sep;17(9):1717-23. doi: 10.1038/oby.2009.100. Epub 2009 Apr 9.
Results Reference
background
Links:
URL
https://www.cdc.gov/diabetes/data/statistics-report/index.html
Description
National Diabetes Statistics Report
URL
https://www.cdc.gov/nccdphp/dnpao/data-trends-maps/index.html
Description
CDC Nutrition, Physical Activity, and Obesity: Data, Trends and Maps
URL
https://www.niddk.nih.gov/about-niddk/research-areas/diabetes/diabetes-prevention-program-dpp
Description
NIH Diabetes Prevention Program
URL
https://www.cdc.gov/diabetes/prevention/index.html
Description
CDC National Diabetes Prevention Program
URL
https://www.cdc.gov/diabetes/prevention/resources/curriculum.html
Description
National Diabetes Prevention Program Curricula
URL
https://www.cdc.gov/diabetes/prevention/pdf/pharmacists-guide.pdf
Description
RX for the National Diabetes Prevention Program
URL
https://www.cdc.gov/prediabetes/pdf/Prediabetes-Risk-Test-Final.pdf
Description
Prediabetes Risk Test

Learn more about this trial

Diabetes Prevention Program to Treat Overweight and Obesity

We'll reach out to this number within 24 hrs